Jove
Visualize
Contact Us

Related Concept Videos

Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrophysiological markers of subclinical central nervous system involvement in patients with non-small-cell lung cancer without brain metastases.

Neurologia i neurochirurgia polska·2026
Same author

Microbiota and mycobiota in chronic inflammatory demyelinating polyneuropathy: clinical and pathophysiological correlations.

Frontiers in molecular neuroscience·2026
Same author

Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

Cephalalgia : an international journal of headache·2026
Same author

Sleep quality and chronotype in primary headache disorders: a nationwide population-based study of 5,311 Polish adults.

The journal of headache and pain·2026
Same author

Altered peroneus longus activation strategies in male athletes with chronic ankle Instability: Insights from traditional and spike shape EMG analyses.

Journal of biomechanics·2026
Same author

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Cephalalgia : an international journal of headache·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 24, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

Myometry revealed medication-induced decrease in resting skeletal muscle stiffness in Parkinson's disease patients.

Jarosław Marusiak1, Anna Jaskólska, Magdalena Koszewicz

  • 1Department of Kinesiology, Faculty of Physiotherapy, University School of Physical Education, Al. I.J. Paderewskiego 35,Wroclaw, Poland. jarekmarusiak@gmail.com

Clinical Biomechanics (Bristol, Avon)
|February 28, 2012
PubMed
Summary

Anti-parkinsonian medication reduces rigidity and resting muscle stiffness in Parkinson's disease (PD) patients. Myometry offers an objective way to assess treatment effectiveness for PD rigidity.

Related Experiment Videos

Last Updated: May 24, 2026

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

Area of Science:

  • Neurology
  • Biomedical Engineering
  • Rehabilitation Medicine

Background:

  • Parkinson's disease (PD) is characterized by rigidity, a symptom often treated with medication.
  • Previous studies confirm anti-parkinsonian drugs reduce clinical rigidity using electromyography or dynamometry.
  • Myometry, a method for assessing soft tissue mechanical properties, has not been utilized to evaluate medication effects on PD-related muscle stiffness.

Purpose of the Study:

  • To investigate the impact of anti-parkinsonian medication on resting muscle stiffness in PD patients.
  • To determine if myometry can objectively measure medication-induced changes in muscle stiffness related to PD rigidity.

Main Methods:

  • Myometry and surface electromyography were used to measure resting muscle stiffness and muscle activity.
  • Measurements were taken on ten PD patients (age 51-80, Hoehn and Yahr stage 2.5-4) during medication on-phase and off-phase (12 hours post-withdrawal).
  • Tested muscles included biceps brachii, brachioradialis, and triceps brachii.

Main Results:

  • Patients exhibited significantly lower myometric stiffness and electromyogram amplitude in all tested muscles during the medication on-phase compared to the off-phase.
  • Clinical rigidity scores were also significantly lower in the on-phase.

Conclusions:

  • Myometry demonstrated that anti-parkinsonian medication effectively decreases resting skeletal muscle stiffness associated with rigidity in PD.
  • These findings suggest myometry is a valuable tool for objectively assessing the effectiveness of treatments for Parkinson's disease rigidity.